ARS Pharmaceuticals: president and CEO Casale Donn received 1,036,923 shares

What happened

• Casale Donn, president and CEO and a director, received a derivative award of 1,036,923 shares on Oct 1, 2026. Price reported: $0.00 per share; total reported value: $0.00. Transaction code: A (award/grant).

Key details

• Transaction date and price: Oct 1, 2026; $0.00 per share.
• Shares owned after the transaction: not stated in the provided filing.
• Vesting/other footnote: 25% of the shares subject to the option vest on Jul 7, 2027, and the remaining shares vest monthly thereafter over 3 years (footnote F1).
• Filing timeliness: not indicated in the provided filing.

Why it may matter

• This filing reports an award/grant of derivative securities, not a market purchase or sale.
• A filing does not show why the insider traded or why the company acted.